pBABEbleo-Flag-BRAFV600E Citations (6)
Originally described in: Copper is required for oncogenic BRAF signalling and tumorigenesis.Brady DC, Crowe MS, Turski ML, Hobbs GA, Yao X, Chaikuad A, Knapp S, Xiao K, Campbell SL, Thiele DJ, Counter CM Nature. 2014 Apr 9. doi: 10.1038/nature13180. PubMed Journal
Articles Citing pBABEbleo-Flag-BRAFV600E
Articles |
---|
Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown. Zhang P, Feng S, Liu G, Wang H, Zhu H, Ren Q, Bai H, Fu C, Dong C. J Biol Chem. 2016 Jan 29;291(5):2087-106. doi: 10.1074/jbc.M115.696419. Epub 2015 Oct 26. PubMed |
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma. Dela Cruz FS, Diolaiti D, Turk AT, Rainey AR, Ambesi-Impiombato A, Andrews SJ, Mansukhani MM, Nagy PL, Alvarez MJ, Califano A, Forouhar F, Modzelewski B, Mitchell CM, Yamashiro DJ, Marks LJ, Bender JL, Kung AL. Genome Med. 2016 Oct 31;8(1):116. PubMed |
Multivalent Small-Molecule Pan-RAS Inhibitors. Welsch ME, Kaplan A, Chambers JM, Stokes ME, Bos PH, Zask A, Zhang Y, Sanchez-Martin M, Badgley MA, Huang CS, Tran TH, Akkiraju H, Brown LM, Nandakumar R, Cremers S, Yang WS, Tong L, Olive KP, Ferrando A, Stockwell BR. Cell. 2017 Feb 23;168(5):878-889.e29. doi: 10.1016/j.cell.2017.02.006. PubMed |
The genomic landscape of pediatric myelodysplastic syndromes. Schwartz JR, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, Song G, Wu G, Easton J, Kesserwan C, Nichols KE, Mullighan CG, Ribeiro RC, Klco JM. Nat Commun. 2017 Nov 16;8(1):1557. doi: 10.1038/s41467-017-01590-5. PubMed |
BRAF(V600E) Overrides NOTCH Signaling in Thyroid Cancer. Traversi F, Stooss A, Dettmer MS, Charles RP. Thyroid. 2021 May;31(5):787-799. doi: 10.1089/thy.2019.0595. Epub 2020 Nov 12. PubMed |
BRAFV600E-Driven Lung Adenocarcinoma Requires Copper to Sustain Autophagic Signaling and Processing. Tsang T, Gu X, Davis CI, Posimo JM, Miller ZA, Brady DC. Mol Cancer Res. 2022 Jul 6;20(7):1096-1107. doi: 10.1158/1541-7786.MCR-21-0250. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.